| Item | Name | Cat. No. | Tag/Conjugates |
| Anti-TNF/TNFA mAbs [Golimumab Biosimilar] (MABL-4766) | MABL-4766 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-OLR1/LOX1 mAbs [Golocdacimab Biosimilar] (MABL-4767) | MABL-4767 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-Respiratory Syncytial Virus Glycoprotein F;Respiratory Syncytial Virus Glycoprotein F mAbs [Gon | MABL-4768 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-IGF1R/CD221 mAbs [Ganitumab Biosimilar] (MABL-4741) | MABL-4741 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-APP mAbs [Gantenerumab Biosimilar] (MABL-4742) | MABL-4742 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-F12 mAbs [Garadacimab Biosimilar] (MABL-4743) | MABL-4743 | ELISA, FACS, Functional assay, in vivo binding | G4, Lambda |
| Anti-CLDN18 mAbs [Garetatug Biosimilar] (MABL-4744) | MABL-4744 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-INHBA mAbs [Garetosmab Biosimilar] (MABL-4745) | MABL-4745 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDL1/CD274 mAbs [Garivulimab Biosimilar] (MABL-4746) | MABL-4746 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MUC1/PEM/EMA mAbs [Gatipotuzumab Biosimilar] (MABL-4747) | MABL-4747 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD52 mAbs [Gatralimab Biosimilar] (MABL-4748) | MABL-4748 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Influenza A HA mAbs [Gedivumab Biosimilar] (MABL-4749) | MABL-4749 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-C5;ALB mAbs [Gefurulimab Biosimilar] (MABL-4750) | MABL-4750 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-SIGLEC3/CD33/p67 mAbs [Gemtuzumab Biosimilar] (MABL-4751) | MABL-4751 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Geptanolimab Biosimilar] (MABL-4752) | MABL-4752 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL1B mAbs [Gevokizumab Biosimilar] (MABL-4753) | MABL-4753 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-CALCA and CALCB mAbs [Fremanezumab Biosimilar] (MABL-4725) | MABL-4725 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-Fel d 1 mAbs [Freneslerbart Biosimilar] (MABL-4726) | MABL-4726 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-TGFB mAbs [Fresolimumab Biosimilar] (MABL-4727) | MABL-4727 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD40LG/CD154 mAbs [Frexalimab Biosimilar] (MABL-4728) | MABL-4728 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
